On this page
Carimune, Carimune Nf, Panglobulin, Sandoglobulin
Immune Globulin Intravenous (Human)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Carimune, Carimune Nf, Panglobulin, Sandoglobulin
Proper name
Immune Globulin Intravenous (Human)
Licence type
351(a)
BLA number
102367
Applicant
CSL Behring AG
Center
CBER
Presentations
3
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 12G | For Injection | Intravenous | Single-Dose Vial | Disc | July 27, 2000 |
| 3G | For Injection | Intravenous | Single-Dose Vial | Disc | July 27, 2000 |
| 6G | For Injection | Intravenous | Single-Dose Vial | Disc | July 27, 2000 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |